A5059413618- Diabetes Treatment and Management
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Hormonal and reproductive studies
- Diabetic Foot Ulcer Assessment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Sexual function and dysfunction studies
- Pancreatic function and diabetes
- Wound Healing and Treatments
- Pharmacology and Obesity Treatment
- Peptidase Inhibition and Analysis
- Neuroendocrine Tumor Research Advances
- Diet and metabolism studies
- Diabetes Management and Education
- Pressure Ulcer Prevention and Management
- Bariatric Surgery and Outcomes
- Liver Disease Diagnosis and Treatment
- Peripheral Artery Disease Management
- Diabetes and associated disorders
- Heart Failure Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Eating Disorders and Behaviors
- Cardiovascular Function and Risk Factors
- Neuropeptides and Animal Physiology
- Peroxisome Proliferator-Activated Receptors
University of Florence
2016-2025
Azienda Ospedaliero-Universitaria Careggi
2016-2025
Ospedale San Donato
2024
Camera di Commercio di Firenze
2012-2013
Academy of Emergency Medicine and Care
2013
University of Naples Federico II
2010
Hypertension Institute
2009
Italian Society of Periodontology and Implantology
2009
Agenzia Regionale di Sanità della Toscana
2006
Azienda Sanitaria di Firenze
2004
Hypoglycemic treatments could modulate the risk for fractures in many ways. Most studies have not explored effect on incidence of bone individual oral hypoglycemic agents, rather all as a whole. The aim this case-control study, nested within retrospective cohort, is assessment associated with exposure to insulin or different agents.A study cohort 1,945 diabetic outpatients follow-up 4.1 +/- 2.3 years was performed, comparing 83 case subjects and 249 control matched age, sex, duration...